Document Detail


The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study.
MedLine Citation:
PMID:  10619579     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Obesity is a significant risk factor for hypertension and the cardiovascular sequelae of hypertension. Weight loss has been shown to be effective in lowering blood pressure in overweight individuals. The purpose of this study was to show the impact of a weight loss intervention on overall medication requirements for obese, hypertensive patients. This was a substudy of the Hypertension Optimal Treatment (HOT) study. HOT study patients who had a body mass index > or =27 kg/m2 were randomized to receive either the weight loss intervention, which included dietary counseling and group support, or to serve as the control group. Patients' weights and number of medication steps (per HOT protocol) required to achieve target diastolic blood pressure were measured at 3, 6, 12, 18, 24, and 30 months. Patients in the weight loss group lost significantly more weight than the control group only at 6 months (-3.2+/-4.3 v. -1.8+/-2.7 kg [mean +/- SD] for weight loss group versus control, respectively, P = .05). The weight loss group tended to regain weight after the first 6 months of the study. However, patients in the weight loss group used a significantly fewer number of medication steps than the control group at all time intervals except 3 months. Weight loss appears to be a useful tool in blood pressure management in patients who require medication to control their blood pressure.
Authors:
D W Jones; M E Miller; M R Wofford; D C Anderson; M E Cameron; D L Willoughby; C T Adair; N S King
Related Documents :
18283269 - Children and adolescents with obesity and the metabolic syndrome have high circulating ...
8554729 - Effect of weight loss on blood pressure and insulin resistance in normotensive and hype...
16135939 - Birth characteristics and risk of high systolic blood pressure in early adulthood: soci...
18830709 - Blood pressure levels in childhood: probing the relative importance of birth weight and...
7315999 - The child-adolescent blood pressure study: i. distribution of blood pressure levels in ...
16751109 - Overweight, obesity and elevated blood pressure in children and adolescents.
24963039 - Arterial blood pressure and vascular function in human saphenous vein.
23572479 - Variables associated with change in blood pressure control status after 1-year follow u...
756059 - Impotence and blood pressure in the flaccid penis: relationship to nocturnal penile tum...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of hypertension     Volume:  12     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-20     Completed Date:  2000-01-20     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1175-80     Citation Subset:  IM    
Affiliation:
Center for Excellence in Cardiovascular-Renal Research, Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505, USA. djones@medicine.umsmed.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use*
Blood Pressure
Body Mass Index
Calcium Channel Blockers / therapeutic use
Diet
Disease Progression
Drug Therapy, Combination
Enalapril / therapeutic use
Felodipine / therapeutic use
Female
Humans
Hypertension / therapy*
Male
Metoprolol / therapeutic use
Middle Aged
Obesity / therapy
Risk Factors
Treatment Outcome
Weight Loss*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 37350-58-6/Metoprolol; 72509-76-3/Felodipine; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus.
Next Document:  A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assesse...